IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- And GM-CSF-deflcient mice

Blood

Volumn 111, Issue 8, 2008, Pages 3978-3985

  Walker, Francesca ^a,d   Zhang, Hui Hua ^a   Matthews, Vance ^b   Weinstock, Janet ^a   Nice, Edouard C ^a   Ernst, Matthias ^a   Rose John, Stefan ^c   Burgess, Antony W ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF KIEL   (Germany)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LIPOPOLYSACCHARIDE; HYBRID PROTEIN; SGP130FC PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CANDIDA ALBICANS; CELL DIFFERENTIATION; COMPLEX FORMATION; CYTOKINE RELEASE; GRANULOCYTE; GRANULOPOIESIS; IMMUNE RESPONSE; IN VITRO STUDY; KNOCKOUT MOUSE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL COUNT; CELL FRACTIONATION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; FIBROBLAST; METABOLISM; MONOCYTE; MOUSE MUTANT; SOLUBILITY; SURVIVAL RATE;

ANIMALS; BONE MARROW CELLS; CELL COUNT; CULTURE MEDIA, CONDITIONED; FIBROBLASTS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; MONOCYTES; NEUTROPHILS; RECEPTORS, INTERLEUKIN-6; RECOMBINANT FUSION PROTEINS; SOLUBILITY; SUBCELLULAR FRACTIONS; SURVIVAL RATE;

EID: 43249126058     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-10-119636     Document Type: Article

References (36)

1. Burgess AW, Wilson EM, Metcalf D. Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood. 1977;49:573-583.
2. Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 1980;56:947-958.
3. Lopez AF, Nicola NA, Burgess AW, et al. Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol. 1983;131:2983-2988.
4. Metcalf D, Begley CG, Nicola NA. The proliferative effects of human GM-CSF alpha and beta and murine G-CSF in microwell cultures of fractionated human marrow cells. Leuk Res. 1985;9:521-527.
5. Lieschke GJ, Stanley E, Grail D, et al. Mice lacking both macrophage- and granulocyte- macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood. 1994;84:27-35.
6. Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor- deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A. 1994;91:5592-5596.
7. Seymour JF, Lieschke GJ, Grail D, et al. Mice lacking both granulocyte colony-stimulating factor (GSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood. 1997;90:3037-3049.
8. Basu S, Hodgson G, Zhang HH, et al. "Emergency" granulopoiesis in G-CSF-deficient mice in response to Gandida albicans infection. Blood. 2000:95:3725-3733.
9. Zhang HH, Basu S, Wu F, et al. Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM- CSF. J Leukoc Biol. 2007;82:915-925.
10. Pojda Z, Tanaka K, Aoki Y, Tsuboi A. In vivo and in vitro interaction between interleukin 6 and granulocyte colony-stimulating factor in the regulation of murine hematopoiesis. Exp Hematol. 1992;20:874-878.
11. Romani L, Mencacci A, Cenci E, et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med. 1996;183:1345-1355.
12. Humphrey RK, Beattie GM, Lopez AD, et al. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Gells. 2004;22:522-530.
13. Peters M, Muller AM, Rose-John S. lnterleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130and hematopoiesis. Blood. 1998;92:3495-3504.
14. Audet J, Miller CL, Rose-John S, Piret JM, Eaves CJ. Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells. Proc Natl Acad Sci USA. 2001;98:1757-1762.
15. Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta. 2002;1592:323-343.
16. Peters M, Schirmacher P, Goldschmitt J, et al. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sll-6R double transgenic mice. J Exp Med. 1997;185:755-766.
17. Liu F, Poursine-Laurent J, Wu HY, Link DC. lnterleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood. 1997;90:2583-2590.
18. Fischer M, Goldschmitt J, Peschel C, et al. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol. 1997;15:142-145.
19. Jostock T, Mullberg J, OzbekS, et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem. 2001;268:160-167.
20. Seymour JF, Lieschke GJ, Grail D, et al. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage GSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood. 1997;90:3037-3049.
21. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994;368:339-342.
22. Guleria I, Pollard JW. Aberrant macrophage and neutrophil population dynamics and impaired Th1 response to Listeria monocytogenes in colony-stimulating factor 1-deficient mice. Infect Immun. 2001;69:1795-1807.
23. Murphy GM Jr, Yang L, Gordell B. Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J Biol Chem. 1998;273:20967-20971.
24. Walev I, Vollmer P, Palmer M, Bhakdi S, Rose-John S. Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccha-ride. Proc Natl Acad Sci U S A. 1996;93:7882-7887.
25. Vollmer P, Walev I, Rose-John S, Bhakdi S. Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor. Infect Immun. 1996;64:3646-3651.
26. Gomez ML, Sokol SH, Muir AB. etal. Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling. J Immunol. 2005;175:1930-1936.
27. Matthews V, Schuster B, Schutze S, et al. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM 10 and ADAM 17 (TACE). J Biol Chem. 2003;278:38829-38839.
28. Mullberg J, Vollmer P, Althoff K, Marz P, Rose-John S. Generation and function of the soluble interleukin-6 receptor. Biochem Soc Trans. 1999;27:211-219.
29. Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med. 1989;170:1409-1414.
30. May LT, Viguet H, Kenney JS, et al. High levels of "complexed" interleukin-6 in human blood. J Biol Chem. 1992;267:19698-19704.
31. Muller-Newen G, Kohne C, Keul R, et al. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. Eur J Biochem. 1996;236:837-842.
32. McLoughlin RM, Hurst SM, Nowell MA, et al. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J Immunol. 2004;172:5676-5683.
33. McLoughlin RM, Witowski J. Robson RL, et al. Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest. 2003;112:598-607.
34. Hurst SM, Wilkinson TS, McLoughlin RM, et al. II-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 2001;14:705-714.
35. Chalaris A, Rabe B, Paliga K, et al. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood. 2007;110:1748-1755.
36. Cheers C, Haigh AM, KelsoA, et al. Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun. 1988;56:247-251.